NCT00283387 - Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Hyperoxaluria

Interventions

DRUG

Betaine

Subjects were randomly assigned oral betaine 12 grams/day in subjects younger than 10 years of age, and 20 grams/day in subjects 10 years of age and older, in two divided doses, for 2 months.

DRUG

Placebo

Subjects received oral lactose placebo, in two doses daily, for 2 months.

Trial Locations (1)

55905

Mayo Clinic Hyperoxaluria Center, Rochester